Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & Administrative
Others
Ratios

AC Immune (ACIU) Depreciation & Amortization - Total (2016)

Historic Depreciation & Amortization - Total for AC Immune (ACIU) over the last 3 years, with Q4 2016 value amounting to -$278006.8.

  • AC Immune's Depreciation & Amortization - Total rose 414.31% to -$278006.8 in Q4 2016 from the same period last year, while for Sep 2017 it was -$278006.8, marking a year-over-year increase of 414.31%. This contributed to the annual value of -$2.1 million for FY2021, which is 2810.43% down from last year.
  • Per AC Immune's latest filing, its Depreciation & Amortization - Total stood at -$278006.8 for Q4 2016, which was up 414.31% from -$290022.7 recorded in Q4 2015.
  • AC Immune's Depreciation & Amortization - Total's 5-year high stood at -$278006.8 during Q4 2016, with a 5-year trough of -$309203.7 in Q4 2014.
  • Moreover, its 3-year median value for Depreciation & Amortization - Total was -$290022.7 (2015), whereas its average is -$292411.1.
  • Its Depreciation & Amortization - Total has fluctuated over the past 5 years, first soared by 620.34% in 2015, then surged by 414.31% in 2016.
  • Quarter analysis of 3 years shows AC Immune's Depreciation & Amortization - Total stood at -$309203.7 in 2014, then rose by 6.2% to -$290022.7 in 2015, then grew by 4.14% to -$278006.8 in 2016.
  • Its Depreciation & Amortization - Total was -$278006.8 in Q4 2016, compared to -$290022.7 in Q4 2015 and -$309203.7 in Q4 2014.